ETRA insider buying and SEC filings, explained
Electra Therapeutics, Inc. · CIK 2088082
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 21, 2026 | Other purchase | Carl L. Gordon (Director and 10% owner) bought 1,333,333 Common Stock indirectly at $15.00 ($20.0M) in a public offering. Indirect holdings up 314% to 1,758,279 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 23, 2026 |
| Sep 21, 2026 | Other purchase | ORBIMED ADVISORS LLC (Director and 10% owner) bought 1,333,333 Common Stock indirectly at $15.00 ($20.0M) in a public offering. Indirect holdings up 314% to 1,758,279 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Sep 23, 2026 |
6 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ETRA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.